ProfileGDS4718 / 236622_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 16% 41% 16% 24% 47% 39% 21% 27% 34% 46% 23% 41% 55% 38% 40% 40% 43% 47% 20% 12% 36% 41% 40% 33% 49% 40% 40% 36% 45% 38% 49% 30% 40% 52% 58% 36% 17% 25% 42% 42% 47% 39% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8346536
GSM549102patient 115, normal, homogenized [OPG study]3.9939116
GSM549104patient 119, normal, homogenized [OPG study]5.0407741
GSM549108patient 138, normal, homogenized [OPG study]4.0291216
GSM549119patient 077, normal, homogenized [OPG study]4.3039524
GSM549133patient 032, cancer, homogenized [OPG study]5.303847
GSM549139patient 042, cancer, homogenized [OPG study]4.9248639
GSM549099patient 107, normal, homogenized [OPG study]4.1863221
GSM549109patient 139, normal, homogenized [OPG study]4.430727
GSM549110patient 046, normal, homogenized [OPG study]4.7066134
GSM549114patient 063, normal, homogenized [OPG study]5.2430246
GSM549122patient 082, normal, homogenized [OPG study]4.257523
GSM549134patient 033, cancer, homogenized [OPG study]5.0334141
GSM549136patient 036, cancer, homogenized [OPG study]5.7667355
GSM549140patient 044, cancer, homogenized [OPG study]4.872338
GSM549111patient 047, normal, homogenized [OPG study]4.9852240
GSM549113patient 057, normal, homogenized [OPG study]4.9181640
GSM549132patient 031, cancer, homogenized [OPG study]5.1246943
GSM549137patient 038, cancer, homogenized [OPG study]5.3056447
GSM549142patient 047, cancer, homogenized [OPG study]4.2248620
GSM549100patient 110, normal, homogenized [OPG study]3.8398312
GSM549107patient 135, normal, homogenized [OPG study]4.7587336
GSM549115patient 068, normal, homogenized [OPG study]5.0056341
GSM549116patient 072, normal, homogenized [OPG study]4.9550840
GSM549120patient 078, normal, homogenized [OPG study]4.6665733
GSM549131patient 030, cancer, homogenized [OPG study]5.3770349
GSM549118patient 074, normal, homogenized [OPG study]4.9957240
GSM549129patient 027, cancer, homogenized [OPG study]5.0218540
GSM549123patient 088, normal, homogenized [OPG study]4.7754736
GSM549124patient 006, cancer, homogenized [OPG study]5.2573945
GSM549126patient 015, cancer, homogenized [OPG study]4.8969138
GSM549128patient 025, cancer, homogenized [OPG study]5.4412449
GSM549103patient 117, normal, homogenized [OPG study]4.5867530
GSM549117patient 073, normal, homogenized [OPG study]4.9719140
GSM549138patient 041, cancer, homogenized [OPG study]5.6162452
GSM549141patient 045, cancer, homogenized [OPG study]6.0159158
GSM549130patient 028, cancer, homogenized [OPG study]4.8351936
GSM549101patient 111, normal, homogenized [OPG study]4.0375917
GSM549105patient 128, normal, homogenized [OPG study]4.3420525
GSM549106patient 134, normal, homogenized [OPG study]5.0563542
GSM549112patient 048, normal, homogenized [OPG study]5.0874942
GSM549125patient 011, cancer, homogenized [OPG study]5.3413547
GSM549127patient 024, cancer, homogenized [OPG study]4.9410339
GSM549135patient 035, cancer, homogenized [OPG study]5.7098154